FY2019 · ended Dec 31, 2019 · Revenue $208,000, +378.3% YoY · Filed Apr 13, 2021
Glucotrack, Inc. (GCTK) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$15.3 million. As of Jun 30, 2026 it held $1.1 million in cash and investments and $24,000 in total debt.
Revenue
$208,000
+378.3% vs prior year
Net income (TTM)
$4.62M
+208.6% vs year-ago TTM
Operating cash flow (TTM)
$-16.22M
-13.2% vs year-ago TTM
Free cash flow
$-15.34M
-21.8% vs prior year
EPS
$31.22
-99.2% vs prior year
Dividend per share
None
Shares outstanding
1.94M
-92.4% vs prior year
Net cash
$1.10M
as of Jun 30, 2026
Operating margin
1685.6%
FY 2019
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GCTK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rutherford, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1506983
- Former names
- Integrity Applications, Inc. (until Dec 9, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$16.1M | -$14.5M | -$7.1M | -$4.4M | -$4.0M |
| Net income | -$19.4M | -$22.6M | -$7.1M | -$4.4M | -$4.1M |
| Diluted EPS | $31.22 | $4,106.00 | $34.18 | — | $0.26 |
| Operating cash flow | -$15.2M | -$12.5M | -$6.6M | -$3.7M | -$3.8M |
| Free cash flow | -$15.3M | -$12.6M | — | -$3.7M | -$3.8M |
| Total assets | $7.8M | $5.9M | $4.9M | $2.4M | $6.3M |
| Total liabilities | $5.0M | $18.9M | $1.7M | $1.2M | $1.1M |
| Stockholders' equity | $2.8M | -$13.0M | $3.2M | $1.2M | $5.2M |
| Cash and investments | $7.4M | $5.6M | $4.5M | $2.3M | $6.1M |
| Total debt | $33,000 | $59,000 | — | — | $40,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Oct 29, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 28, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Oct 22, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 19, 2026 | Oct 13, 2026 |
| 8-K/A | Amended current report | Oct 13, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 28, 2026 | Sep 22, 2026 |
All 495 Glucotrack, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.